Active, Not Recruiting
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
NCT04211337
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- UCLA Hematology/Oncology - Westwood (Building 100) Los Angeles, California, United States
- University of California Davis (UC Davis) Comprehensive Cancer Center Sacramento, California, United States